Singapore export recovery set to slow as tariff risks escalate

Singapore’s NODX fell by 4.6% YoY, reversing a strong 12.9% surge in June.

Singapore’s export recovery is expected to lose steam in the second half of the year, with CGS International analysts warning that non-oil domestic export (NODX) momentum will likely remain subdued amid escalating tariff risks and uneven global demand.

In its latest Economics Update, CGS International maintained its full-year 2025 NODX growth forecast at 3.3%, slightly above Enterprise Singapore’s official range of 1.0% to 3.0%. However, the research house cautioned that “ongoing tariff risks” and “sector-specific vulnerabilities”—particularly in pharmaceuticals and semiconductors—could weigh on performance.

“We think the NODX momentum will remain subdued amid ongoing tariffs risks,” the analysts wrote in the report.

The July data provided immediate cause for concern. Singapore’s NODX fell by 4.6% YoY, reversing a strong 12.9% surge in June.

The decline was broader than expected and fell short of Bloomberg’s consensus forecast of -1.0%, though it came in slightly better than CGSI’s internal projection of -6.1%.

The most severe drop came from the United States. Exports to the US plunged by 42.7% in July—marking the third consecutive monthly fall—driven by a staggering 93.5% collapse in pharmaceutical shipments, attributed to both production volatility and rising geopolitical tension.

“Trump has flagged the potential for tariffs on pharmaceuticals of up to 250%, which in our view could be prompting buyers to scale back orders until there is greater policy clarity,” CGSI analysts noted.

In contrast, regional shipments held up well. Exports to Taiwan soared by 62.9%, South Korea rose 34.5%, and Hong Kong gained 20.8%. Electronics exports grew a modest 2.8%, bolstered by strong gains in PCs (+80.4%), ICs (+8.0%), and printed circuit boards (+25.8%).

Still, the broad-based decline in non-electronics—especially pharmaceuticals (-18.9%), petrochemicals (-23.4%), and food preparations (-26.3%)—dragged overall performance down and narrowed the trade surplus to $7.1b, from $8.6b in June.

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia